Hakutulokset - Holger Hess‐Stumpp

  • Näytetään 1 - 12 yhteensä 12 tuloksesta
Tarkenna hakua
  1. 1
    Sagopilone crosses the blood–brain barrier in vivo to inhibit brain tumor growth and metastases

    Sagopilone crosses the blood–brain barrier in vivo to inhibit brain tumor growth and metastases Tekijä Jens Hoffmann, Iduna Fichtner, M Lemm, Philip Lienau, Holger Hess‐Stumpp, Andrea Rotgeri, B. Hofmann, Ulrich Klar

    Julkaistu 2008
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  2. 2
    Peritoneal endometriosis: validation of an in-vivo model

    Peritoneal endometriosis: validation of an in-vivo model Tekijä Ruth Grümmer, F Schwarzer, K. Bainczyk, Holger Hess‐Stumpp, Pedro‐Antonio Regidor, A. E. Schindler, E. Winterhager

    Julkaistu 2001
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  3. 3
    Cyr61, a deregulated gene in endometriosis

    Cyr61, a deregulated gene in endometriosis Tekijä Yvonne Absenger, Holger Hess‐Stumpp, Bertolt Kreft, Jörn Krätzschmar, Bernard Haendler, Norbert Schütze, Pedro‐Antonio Regidor, Elke Winterhager

    Julkaistu 2004
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  4. 4
    <i>In vivo</i> properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class

    <i>In vivo</i> properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class Tekijä Britta Wlotzka, Susanne Leva, Bernd Eschgfäller, Jens Burmeister, Frank Kleinjung, Christine Kaduk, Peter Muhn, Holger Hess‐Stumpp, Sven Klußmann

    Julkaistu 2002
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  5. 5
    BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human xenografts

    BAY 87–2243, a novel inhibitor of hypoxia-induced gene activation, improves local tumor control after fractionated irradiation in a schedule-dependent manner in head and neck human... Tekijä L. Helbig, Lydia Koi, Kerstin Brüchner, Kristin Gurtner, Holger Hess‐Stumpp, Kerstin Unterschemmann, Michaël Baumann, Daniel Zips, Ala Yaromina

    Julkaistu 2014
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  6. 6
    <scp>BAY</scp> 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I

    <scp>BAY</scp> 87‐2243, a highly potent and selective inhibitor of hypoxia‐induced gene activation has antitumor activities by inhibition of mitochondrial complex I Tekijä Peter Ellinghaus, Iring Heisler, Kerstin Unterschemmann, Michael Haerter, Hartmut Beck, Susanne Greschat, Alexander Ehrmann, Holger Summer, Ingo Flamme, Felix Oehme, Karl‐Heinz Thierauch, Martin Michels, Holger Hess‐Stumpp, Karl Ziegelbauer

    Julkaistu 2013
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  7. 7
    Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence

    Acetyl-CoA Carboxylase 1-Dependent Protein Acetylation Controls Breast Cancer Metastasis and Recurrence Tekijä Marcos Ríos García, Brigitte Steinbauer, Kshitij Srivastava, Mahak Singhal, Frits Mattijssen, Adriano Maida, Sven Christian, Holger Hess‐Stumpp, Hellmut G. Augustin, Karin Müller‐Decker, Peter P. Nawroth, Stephan Herzig, Mauricio Berriel Díaz

    Julkaistu 2017
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  8. 8
    Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models

    Rogaratinib: A potent and selective pan‐FGFR inhibitor with broad antitumor activity in FGFR‐overexpressing preclinical cancer models Tekijä Sylvia Grünewald, Oliver Politz, Sebastian Bender, Mélanie Héroult, Klemens Lustig, Uwe Thuß, Christoph Kneip, Charlotte Kopitz, Dieter Zopf, Marie-Pierre L. Collin, Ulf Boemer, Stuart Ince, Peter Ellinghaus, Dominik Mumberg, Holger Hess‐Stumpp, Karl Ziegelbauer

    Julkaistu 2019
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  9. 9
    Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: a characterisation study

    Mass cytometry analysis reveals a distinct immune environment in peritoneal fluid in endometriosis: a characterisation study Tekijä Manman Guo, Cemsel Bafligil, Thomas T. Tapmeier, Carol Hubbard, Sanjiv Manek, Catherine A. Shang, Fernando O. Martínez, Nicole Schmidt, Maik Obendorf, Holger Hess‐Stumpp, Thomas M. Zollner, Stephen Kennedy, Christian M. Becker, Krina T. Zondervan, Adam P. Cribbs, Udo Oppermann

    Julkaistu 2020
    Hae kokoteksti Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  10. 10
    Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate

    Lethal Poisoning of Cancer Cells by Respiratory Chain Inhibition plus Dimethyl α-Ketoglutarate Tekijä Valentina Sica, José Manuel Bravo‐San Pedro, Valentina Izzo, Jonathan Pol, Sandra Pierredon, David Enot, Sylvère Durand, Noélie Bossut, Alexis Chery, Sylvie Souquère, Gérard Pierron, Evangelia Vartholomaiou, Naoufal Zamzami, Thierry Soussi, Allan Sauvat, Laura Mondragón, Oliver Kepp, Lorenzo Galluzzi, Jean‐Claude Martinou, Holger Hess‐Stumpp, Karl Ziegelbauer, Guido Kroemer, Maria Chiara Maiuri

    Julkaistu 2019
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  11. 11
    Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo

    Pan-mutant-IDH1 inhibitor BAY1436032 is highly effective against human IDH1 mutant acute myeloid leukemia in vivo Tekijä Anuhar Chaturvedi, Lena Herbst, Stefan Pusch, Lara C. Klett, Ramya Goparaju, Damian Stichel, Silke Kaulfuß, Olaf Panknin, Katja Zimmermann, Luisella Toschi, Roland Neuhaus, Andrea Haegebarth, Hartmut Rehwinkel, Holger Hess‐Stumpp, Marcus Bauser, Tilmann Bochtler, Eduard A. Struys, Amit Sharma, Abdellatif Bakkali, Robert Geffers, M M Araujo-Cruz, Felicitas Thol, Razif Gabdoulline, Arnold Ganser, Anthony D. Ho, Andreas von Deimling, Karsten Rippe, Michael Heuser, A. Krämer

    Julkaistu 2017
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:
  12. 12
    Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis

    Neuropeptide S receptor 1 is a nonhormonal treatment target in endometriosis Tekijä Thomas T. Tapmeier, Nilüfer Rahmioğlu, Jianghai Lin, Bianca De Leo, Maik Obendorf, Muthuswamy Raveendran, Oliver M. Fischer, Cemsel Bafligil, Manman Guo, R. Alan Harris, Holger Hess‐Stumpp, Alexis Laux‐Biehlmann, Ernesto Lowy, Gerton Lunter, Jessica Malzahn, Nicholas G. Martin, Fernando O. Martínez, Sanjiv Manek, Stefanie Mesch, Grant W. Montgomery, Andrew P. Morris, Jens Nagel, Heather A. Simmons, Denise Brocklebank, Catherine A. Shang, Susan A. Treloar, Graham Wells, Christian M. Becker, Udo Oppermann, Thomas M. Zollner, Stephen Kennedy, Joseph W. Kemnitz, Jeffrey Rogers, Krina T. Zondervan

    Julkaistu 2021
    Hae kokoteksti
    Artigo
    Lisää suosikkeihin
    Tallennettuna:

Työkalut: